All Relations between dopaminergic and dopamine

Publication Sentence Publish Date Extraction Date Species
E J Mylecharan. Ventral tegmental area 5-HT receptors: mesolimbic dopamine release and behavioural studies. Behavioural brain research. vol 73. issue 1-2. 1996-12-04. PMID:8788468. these in vivo dopamine release and behavioural studies therefore confirm that 5-ht3 receptors in the vta can mediate increased locomotor activity, by modulating the firing of mesolimbic dopaminergic cell bodies. 1996-12-04 2023-08-12 rat
L J Beerpoot, B K Lipska, D R Weinberge. Neurobiology of treatment-resistant schizophrenia: new insights and new models. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 6 Suppl 2. 1996-12-04. PMID:8792118. early findings that antipsychotic drugs were dopamine antagonists led to a dopaminergic theory of schizophrenia. 1996-12-04 2023-08-12 Not clear
D E Comings, S Wu, C Chiu, R H Ring, R Gade, C Ahn, J P MacMurray, G Dietz, D Muhlema. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1. American journal of medical genetics. vol 67. issue 3. 1996-12-03. PMID:8725745. polymorphisms of three different dopaminergic genes, dopamine d2 receptor (drd2), dopamine beta-hydroxylase (d beta h), and dopamine transporter (dat1), were examined in tourette syndrome (ts) probands, their relatives, and controls. 1996-12-03 2023-08-12 human
K Kuwabara, S Hitoshi, N Nukina, K Ishii, T Momose, S Kubota, Y Seyama, I Kanazaw. PET analysis of a case of cerebrotendinous xanthomatosis presenting hemiparkinsonism. Journal of the neurological sciences. vol 138. issue 1-2. 1996-12-03. PMID:8791252. although mri studies could not detect any abnormality in the basal ganglia or midbrain, pet analysis using [18f]-6-fluoro-l-dopa revealed reduced uptake of dopamine into the putamen, suggesting the impairment of presynaptic dopaminergic neurons. 1996-12-03 2023-08-12 Not clear
C Perrone-Capano, A Tino, G Amadoro, R Pernas-Alonso, U di Porzi. Dopamine transporter gene expression in rat mesencephalic dopaminergic neurons is increased by direct interaction with target striatal cells in vitro. Brain research. Molecular brain research. vol 39. issue 1-2. 1996-12-03. PMID:8804724. dopamine transporter gene expression in rat mesencephalic dopaminergic neurons is increased by direct interaction with target striatal cells in vitro. 1996-12-03 2023-08-12 rat
M F Egan, S J Chrapusta, F Karoum, R J Wyat. The effects of acute and chronic haloperidol treatment on dopamine release mediated by the medial forebrain bundle in the striatum and nucleus accumbens. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 14. issue 3. 1996-12-03. PMID:8866705. the delayed therapeutic effects of neuroleptics have been attributed to d2-mediated depolarization inactivation (di) of mesolimbic dopaminergic neurons and concomitant reduction in dopamine release. 1996-12-03 2023-08-12 rat
E J Mufson, J S Kroin, Y T Liu, T Sobreviela, R D Penn, J A Miller, J H Kordowe. Intrastriatal and intraventricular infusion of brain-derived neurotrophic factor in the cynomologous monkey: distribution, retrograde transport and co-localization with substantia nigra dopamine-containing neurons. Neuroscience. vol 71. issue 1. 1996-11-27. PMID:8834401. sections from these cases dual-immunoreacted for brain-derived neurotrophic factor and tyrosine hydroxylase, the synthesizing enzyme for dopamine, revealed a subpopulation of pars compacta dopaminergic neurons which contained retrogradely transported brain-derived neurotrophic factor. 1996-11-27 2023-08-12 monkey
I Gordon, R Weizman, M Rehav. Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter. European journal of pharmacology. vol 298. issue 1. 1996-11-27. PMID:8867915. modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter. 1996-11-27 2023-08-12 rat
I Gordon, R Weizman, M Rehav. Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter. European journal of pharmacology. vol 298. issue 1. 1996-11-27. PMID:8867915. we have investigated the effects of agents active in the presynaptic dopaminergic system on the characterization of the rat striatal dopamine transporter. 1996-11-27 2023-08-12 rat
I Gordon, R Weizman, M Rehav. Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter. European journal of pharmacology. vol 298. issue 1. 1996-11-27. PMID:8867915. the present results showed that the striatal dopamine transporter is sensitive to changes in dopaminergic neurotransmission caused by agents that do not interact directly with the dopamine carrier. 1996-11-27 2023-08-12 rat
Z J Yang, M M Meguid, M Koseki, A Oler, C Chong, J Boy. Increased food intake and body weight gain after lateral hypothalamic dopaminergic cell implantation. Neuroreport. vol 7. issue 2. 1996-11-25. PMID:8730803. to examine our hypothesis that dopamine activity in the lateral hypothalamic area (lha) may play a role in enhancing the process of eating, a fetal cell suspension of predominantly dopaminergic cells was bilaterally transplanted into the lha of study rats via direct injection; controls had carrier medium injection. 1996-11-25 2023-08-12 rat
M Garcia-Munoz, D S Segal, P Patino, S J Young, R Kuczenski, P M Grove. Amphetamine-induced changes in nigrostriatal terminal excitability are modified following repeated amphetamine pretreatment. Brain research. vol 720. issue 1-2. 1996-11-25. PMID:8782905. the chronic amphetamine-induced change in the effect of an acute intrastriatal amphetamine infusion on nigrostriatal terminal excitability may be due to enduring alterations in the amphetamine-induced release of dopamine and other striatal neurotransmitters or to changes in the sensitivity of presynaptic hetero- and/or autoreceptors on the dopaminergic axons. 1996-11-25 2023-08-12 rat
X M Shen, G Dryhurs. Further insights into the influence of L-cysteine on the oxidation chemistry of dopamine: reaction pathways of potential relevance to Parkinson's disease. Chemical research in toxicology. vol 9. issue 4. 1996-11-19. PMID:8831820. the initial step in the genesis of neuromelanin, a black polymeric pigment normally found in the cytoplasm of dopaminergic cell bodies in the substantia nigra (sn), is the autoxidation of dopamine (da) to da-o-quinone (1). 1996-11-19 2023-08-12 mouse
C M Shaw-Bruha, H K Happe, L C Murrin, J F Rodriguez-Sierra, J D Shul. 17 beta-Estradiol inhibits the production of dopamine by the tuberoinfundibular dopaminergic neurons of the male rat. Brain research bulletin. vol 40. issue 1. 1996-11-18. PMID:8722750. 17 beta-estradiol inhibits the production of dopamine by the tuberoinfundibular dopaminergic neurons of the male rat. 1996-11-18 2023-08-12 rat
C M Shaw-Bruha, H K Happe, L C Murrin, J F Rodriguez-Sierra, J D Shul. 17 beta-Estradiol inhibits the production of dopamine by the tuberoinfundibular dopaminergic neurons of the male rat. Brain research bulletin. vol 40. issue 1. 1996-11-18. PMID:8722750. previous work in our laboratory suggests that the indirect stimulation of prolactin gene transcription observed in male rats between 3 and 6 h following estrogen injection results from an inhibition of dopamine release from the tuberoinfundibular dopaminergic neurons. 1996-11-18 2023-08-12 rat
C M Shaw-Bruha, H K Happe, L C Murrin, J F Rodriguez-Sierra, J D Shul. 17 beta-Estradiol inhibits the production of dopamine by the tuberoinfundibular dopaminergic neurons of the male rat. Brain research bulletin. vol 40. issue 1. 1996-11-18. PMID:8722750. these data suggest that estrogens exert acute inhibitory effects on the tuberoinfundibular dopaminergic neurons of the male rat, and further support the assertion that the indirect stimulatory actions of estrogens on prolactin gene transcription result from inhibition of hypothalamic dopamine production. 1996-11-18 2023-08-12 rat
U Scheffel, C Steinert, S E Kim, M D Ehlers, J W Boja, M J Kuha. Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transporters. Synapse (New York, N.Y.). vol 23. issue 2. 1996-11-18. PMID:8723710. effect of dopaminergic drugs on the in vivo binding of [3h]win 35,428 to central dopamine transporters. 1996-11-18 2023-08-12 mouse
A Lerant, M E Herman, M E Freema. Dopaminergic neurons of periventricular and arcuate nuclei of pseudopregnant rats: semicircadian rhythm in Fos-related antigens immunoreactivities and in dopamine concentration. Endocrinology. vol 137. issue 9. 1996-11-13. PMID:8756525. dopaminergic neurons of periventricular and arcuate nuclei of pseudopregnant rats: semicircadian rhythm in fos-related antigens immunoreactivities and in dopamine concentration. 1996-11-13 2023-08-12 rat
C L Coulter, H K Happe, L C Murri. Postnatal development of the dopamine transporter: a quantitative autoradiographic study. Brain research. Developmental brain research. vol 92. issue 2. 1996-11-08. PMID:8738124. the dopamine transporter performs an important role in regulating neurochemical transmission at dopaminergic synapses, as well as dopamine synthetic activity in dopaminergic neurons. 1996-11-08 2023-08-12 rat
W P Melega, J Quintana, M J Raleigh, D B Stout, D C Yu, K P Lin, S C Huang, M E Phelp. 6-[18F]fluoro-L-DOPA-PET studies show partial reversibility of long-term effects of chronic amphetamine in monkeys. Synapse (New York, N.Y.). vol 22. issue 1. 1996-11-08. PMID:8822479. the apparent, partial reversibility of amphetamine's neurotoxic effects suggests a plasticity of dopaminergic function that may include regeneration of dopaminergic terminals and compensatory increases in residual dopamine synthesis rates. 1996-11-08 2023-08-12 human